AMERISE BIOSCIENCES
AMERISE BIOSCIENCES Share Price Chart
AMERISE BIOSCIENCES last traded at ₹0.78 (2026-10-13). Over the past month the stock moved -4.9%, three months the stock moved +9.9%, year the stock moved +20.0%. Its closing range over 52 weeks is ₹0.57 – ₹0.86, with the latest close 9.3% below the high.
Closing prices up to 2026-10-13.
About AMERISE BIOSCIENCES
Incorporated in 1984, Amradeep Industries Ltd manufactured and traded in Decorative Boards, Laminates Sheets, Boards, and laminates products[1]
Business Overview:[1] AIL manufactures, buys, sells, imports, exports, distributes, and deals in Decorative Boards, Laminates Sheets, Boards, and laminates products in India and abroad
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), AMERISE BIOSCIENCES reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.08 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.08 | – | -0.08 | -0.01 |
| Mar 2026 | 0.08 | 0.06 | 75.00 | 0.06 | 0.01 |
| Dec 2025 | 0.04 | 0.01 | 25.00 | 0.01 | 0.00 |
| Sep 2025 | 0.07 | -0.04 | -57.14 | -0.04 | -0.01 |
| Jun 2025 | 0.06 | -0.01 | -16.67 | -0.01 | 0.00 |
| Mar 2025 | 0.19 | 0.11 | 57.89 | 0.11 | 0.02 |
| Dec 2024 | 0.00 | -0.02 | – | -0.02 | 0.00 |
| Sep 2024 | 0.00 | -0.03 | – | -0.03 | 0.00 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | +375.0% | – | – | – | -57.9% | -100.0% |
| Operating profit growth | – | – | +450.0% | – | – | – | -45.5% | – |
| Net profit growth | – | – | +450.0% | – | – | – | -45.5% | – |
| EPS growth | – | – | – | – | – | – | -50.0% | – |
| OPM % | – | – | 57.9% | -16.7% | -57.1% | 25.0% | 75.0% | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), AMERISE BIOSCIENCES reported sales of ₹0.26 crore (+36.8%) and net profit of ₹0.02 crore (+100.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.26 | 0.02 | 7.69 | 0.02 | 0.00 |
| Mar 2025 | 0.19 | 0.01 | 5.26 | 0.01 | 0.00 |
| Mar 2024 | 0.04 | -0.15 | -375.00 | -0.15 | -0.02 |
| Mar 2023 | 0.01 | -0.12 | -1,200.00 | -0.12 | -0.02 |
| Mar 2022 | 9.58 | 0.55 | 5.74 | 0.55 | 0.08 |
| Mar 2021 | 0.00 | -0.17 | – | -0.34 | -0.05 |
| Mar 2020 | 0.00 | -0.15 | – | -0.15 | -0.02 |
| Mar 2019 | 1.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | -100.0% | – | – | -99.9% | +300.0% | +375.0% | +36.8% |
| Operating profit growth | – | – | – | – | -121.8% | – | – | +100.0% |
| Net profit growth | – | – | – | – | -121.8% | – | – | +100.0% |
| EPS growth | – | – | – | – | -125.0% | – | – | – |
| OPM % | 0.0% | – | – | 5.7% | -1200.0% | -375.0% | 5.3% | 7.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
AI Analysis
No AI analysis generated yet for AMERISE BIOSCIENCES.
Get Free AI Stock Analysis FREE →Latest News
-
Amerise Biosciences reports Profit after tax of Rs -0.81 Mln, in the June 2026 quarter
-
Amerise Biosciences standalone net profit declines 45.45% in the March 2026 quarter - Business Standard
-
Amerise Biosciences standalone net profit declines 45.45% in the March 2026 quarter - Business Standard
-
Amerise Biosciences Limited Reports Audited Standalone Financial Results for Year Ended March 31, 2026 - scanx.trade
Frequently Asked Questions
What is AMERISE BIOSCIENCES's current stock price?
AMERISE BIOSCIENCES shares were last quoted at ₹0.78 (-2.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of AMERISE BIOSCIENCES?
AMERISE BIOSCIENCES has a price-to-earnings (P/E) ratio of -81.00 and a price-to-book (P/B) ratio of 1.01. The industry P/E is 53.33.
What is the 52-week high and low of AMERISE BIOSCIENCES?
The 52-week high of AMERISE BIOSCIENCES is ₹1.03 and the 52-week low is ₹0.50.
What is the market cap of AMERISE BIOSCIENCES?
The market capitalisation of AMERISE BIOSCIENCES is about ₹5.35 crore.
How did AMERISE BIOSCIENCES perform in its latest quarterly results?
In the latest quarter (Jun 2026), AMERISE BIOSCIENCES reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.08 crore, compared with the same quarter last year.
Is AMERISE BIOSCIENCES a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, AMERISE BIOSCIENCES has a 3-year ROE of -1.00%, 3-year profit growth of 29.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Which sector does AMERISE BIOSCIENCES belong to?
AMERISE BIOSCIENCES belongs to the Labs & Life Sciences Services sector.
Other Labs & Life Sciences Services stocks
- Syngene International
- Vimta Labs
- Suraksha Diagnostic
- Quest Laboratories
- Gujarat Inject (Kerala)
- Star Imaging & Path Lab
- Modern Diagnostic & Research Centre
- Invicta Diagnostic
All Labs & Life Sciences Services stocks · Browse all stocks A–Z